Drug Topics - April 14, 2008 - (Page 6)

6 DRUG TOPICS APRIL 14, 2008 www.drugtopics.com EDITORIAL E - -C Judy C. Chi (201) 690-5327 jchi@advanstar.com C E Heidi Belden, Pharm.D. (508) 846-4165 hbelden@advanstar.com M E -P Sandra Levy (201) 690-5396 slevy@advanstar.com S E Reid Paul (201) 690-5392 rpaul@advanstar.com C E Fred Gebhart Jim Plagakis, R.Ph. E C Nedda Tichi (201) 690-5398 ntichi@advanstar.com SALES & MARKETING P Rick Stefany (201) 690-5397 rstefany@advanstar.com S A M Maureen Dominguez (201) 690-5328 mdominguez@advanstar.com A A Melissa Gallagher (440) 891-2699 M D Susan Haber (201) 690-5403 LM Tamara Phillips (440)891-2773 C R Scott Eigenbrod (800) 225-4569 ext. 3170 C S Karen Eckenwiler (800) 225-4569 ext. 2670 R S FosteReprints (800) 344-8915 advanstarreprints @fostereprints.com PRODUCTION S AD Pete Seltzer (440) 891-3108 AD Robert Siani (201) 690-5559 S G D Sandy Schultz (201) 690-5557 G D Sindi Price (201) 690-5556 S P Jane Dzuck (218) 740-6313 CIRCULATION D ,C Mark Rosen (201) 690-5315 RESEARCH D ,C R Harry Ann Pearce (212) 951-6670 S S S Scott Spiegel (212) 951-6649 M 123 Tice Boulevard, Suite 300 Woodcliff Lake, N.J. 07677 Main numbers: (201) 690-5300 or (888) 581-8052 Main fax number: (201) 690-5400 Customer Service: 1-877-922-2022 Classified and Recruitment Sales: 800-225-4569 ext. 2701 E-mail address: drugtopics@advanstar.com Web site: http://www.drugtopics.com Business hours: 8:30 a.m.–5:00 p.m. EST E H R. Steve Morris VP P /S G Laura Wagner P O P C Tara Stultz E D P C P David Hoo M V E V C E Joseph Loggia E O Ted Alpert VP F , CFO R. Steve Morris VP P /S G E , Francis Heid VP , M O V C Rick Treese P T O V Mike Alic P , M G E H Ward D. Hewins VP , G C Nancy Nugent VP H R V Shelbie O’Brien P C Drug Topics (ISSN# 0012-6616) is published monthy and Drug Topics Digital Edition (ISSN# 1937-8157) is issued every week by Advanstar Communications, Inc., 131 West First St., Duluth, MN 55806-2065. One-year subscription rates: $61 in the United States & Possessions; $109 in Canada and Mexico; all other countries, $109. Single copies (prepaid only) $10 in the United States; $10 in Canada and Mexico; all other countries, $15. Include $6 per copy for U.S. postage and handling. Periodicals postage paid at Duluth, MN 55806 and additional mailing offices. POSTMASTER: Please send address changes to Drug Topics, P.O. Box 6079, Duluth, MN 55806-6079. Canadian G.S.T. number: R-124213133RT001. Publications Mail Agreement Number 40017597. Printed in the U.S.A. Subscription inquiries/address changes: toll-free (888) 527-7008, or dial direct (218) 723-9477. Copyright ©2008 Advanstar Communications Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/educational or personal use, or the internal/educational or personal use of specific clients is granted by Advanstar Communications Inc. for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700. For uses beyond those listed above, please direct your written request to Permission Dept. fax 440-891-2650. Microfilm or microfiche copies of issues are available through Advanstar Marketing Services, (800) 225-4569, Ext. 839. Unsolicited manuscripts, photographs, art, and other material will not be returned. Publisher assumes no responsibility for unsolicited manuscripts, photographs, art, and other material. Advanstar Communications provides certain customer contact data (such as customers’ names, addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call toll-free (888) 527-7008 between the hours of 7:30 am and 5 pm CT and a customer service representative will assist you in removing your name from Advanstar’s lists. Outside the U.S., please phone (218) 723-9477. DRUG TOPICS does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance on such content. DRUG TOPICS welcomes unsolicited articles, manuscripts, photographs and other materials but cannot be held responsible for their safekeeping or return. http://www.drugtopics.com http://www.drugtopics.com

Table of Contents Feed for the Digital Edition of Drug Topics - April 14, 2008

Drug Topics - March 14, 2008 Contents Latebreakers Letters: Students Need Grounding in Chemistry Pharmacy Directors Wary of Heparin Shortages Some E-prescribing Standards are Ready to Go, Others are Not News Briefs Nanotechnology: Big Stakes in a Small World Pay for Performance is Coming to Pharmacy Patient Safety Organizations Still Very Much in Planning Stage Reconciling Medications in Specialty Patients Poses More Challenges Pharmacy Outsourcing Still Much in Use by Hospitals Studied Extensively, New Drug-Eluting Stent Said to be Very Safe Prevention is Key in Treating C. Difficile Infections E-prescribing Grows in Massachusetts, but Other States Lag Behind Active Metabolite Gives New Life to Antidepressant NSAIDS not Recommended for Long-term Use in Osteoarthritis This Time R.Ph.s and States Are Ready for Tamper-Resistant Rx Pads Cardinal Caught Between DEA and Pharmacies over Diversion Control Medicating Kids: Still More Questions than Answers Schnucks Pharmacy: Drug Topics' Chain of the Year Panel Will Ask for a System for R.Ph. Practice Across State Lines FDA Safety Page: How to use Fentora Safely The Shining OTC/HBC Stars of 2007 Take a Look at These OTCs for Eye Health Technology Update: Google Offers a Sneak Peak at its Electronic Records Initiative Recent Advancements in HIV/AIDS Treatment New Products Advertisers Index Classified Viewpoint: Are State Boards of Pharmacy Abusing Their Power?

Drug Topics - April 14, 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.